Cytotoxicity responses to selected ESAT-6 and CFP-10 peptides in tuberculosis

Cellular Immunology

Volumn 265, Issue 2, 2010, Pages 146-155

  Madhan Kumar, M ^a   Raja, Alamelu ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

CFP 10; Cytotoxicity; ESAT 6; Granulysin; Granzyme; Perforin

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GRANULYSIN; GRANZYME A; GRANZYME B; LACTATE DEHYDROGENASE; PERFORIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HOUSEHOLD; HUMAN; HUMAN CELL; IMMUNOGENICITY; LUNG TUBERCULOSIS; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FAMILY; FEMALE; GRANZYMES; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PEPTIDES; RECOMBINANT PROTEINS; TUBERCULOSIS, PULMONARY;

EID: 77957017073     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.08.004     Document Type: Article

References (61)

1. Louise R., Skjot V., Agger E.M., Andersen P. Antigen discovery and tuberculosis vaccine development in the post-genomic era. Scand. J. Infect. Dis. 2001, 33(9):643-647.
2. Mustafa A.S. Development of new vaccines and diagnostic reagents against tuberculosis. Mol. Immunol. 2002, 39(1-2):113-119.
3. Berthet F.X., Rasmussen P.B., Rosenkrands I., Andersen P., Gicquel B. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 1998, 144(Pt. 11):3195-3203.
4. Langermans J.A., Doherty T.M., Vervenne R.A., van der Laan T., Lyashchenko K., Greenwald R., Agger E.M., Aagaard C., Weiler H., van Soolingen D., Dalemans W., Thomas A.W., Andersen P. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 2005, 23(21):2740-2750.
5. Pollock J.M., Buddle B.M., Andersen P. Towards more accurate diagnosis of bovine tuberculosis using defined antigens. Tuberculosis (Edinb) 2001, 81(1-2):65-69.
6. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol. 2003, 3:361-370.
7. Russell J.H., Ley T.J. Lymphocyte-mediated cytotoxicity, Annu. Rev. Immunol. 2002, 20:323-370.
8. Stinchcombe J.C., Griffiths G.M. Secretory mechanisms in cell-mediated cytotoxicity. Annu. Rev. Cell. Dev. Biol. 2007, 23:495-517.
9. Keefe D., Shi L., Feske S., Massol R., Navarro F., Kirchhausen T., Lieberman J. Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis. Immunity 2005, 23(3):249-262.
10. D. Zhang, P.J. Beresford, A.H. Greenberg, J. Lieberman, Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis, Proc. Natl. Acad. Sci. USA 98 (10) (2001) 5746-5751.
11. Okada S., Li Q., Whitin J.C., Clayberger C., Krensky A.M. Intracellular mediators of granulysin-induced cell death. J. Immunol. 2003, 171(5):2556-2562.
12. Stenger S., Hanson D.A., Teitelbaum R., Dewan P., Niazi K.R., Froelich C.J., Ganz T., Thoma-Uszynski S., Melian A., Bogdan C., Porcelli S.A., Bloom B.R., Krensky A.M., Modlin R.L. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998, 282(5386):121-125.
13. Temmerman S.T., Place S., Debrie A.S., Locht C., Mascart F. Effector functions of heparin-binding hemagglutinin-specific CD8+ T lymphocytes in latent human tuberculosis. J. Infect. Dis. 2005, 192(2):226-232.
14. Worku S., Hoft D.F. Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. Infect. Immun. 2003, 71(4):1763-1773.
15. Canaday D.H., Wilkinson R.J., Li Q., Harding C.V., Silver R.F., Boom W.H. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J. Immunol. 2001, 167(5):2734-2742.
16. Lewinsohn D.M., Alderson M.R., Briden A.L., Riddell S.R., Reed S.G., Grabstein K.H. Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J. Exp. Med. 1998, 187(10):1633-1640.
17. Esin S., Batoni G., Kallenius G., Gaines H., Campa M., Svenson S.B., Andersson R., Wigzell H. Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Mycobacterium avium. Clin. Exp. Immunol. 1996, 104(3):419-425.
18. Turner J., Dockrell H.M. Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro. Immunology 1996, 87(3):339-342.
19. Denis O., Tanghe A., Palfliet K., Jurion F. T. P. van den Berg, A. Vanonckelen, J. Ooms, E. Saman, J. B. Ulmer, J. Content, K. Huygen, Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect. Immun. 1998, 66(4):1527-1533.
20. Selvakumar N. Vanajakumar, P.G. Gopi, K. V. Venkataramu, M. Datta, C. N. Paramasivan, R. Prabhakar, Isolation of tubercle bacilli from sputum samples of patients in the field studies by the cetylpyridinium chloride-sodium chloride and sodium hydroxide methods. Indian J. Med. Res. 1995, 102:149-151.
21. Ganguly N., Giang P.H., Basu S.K., Mir F.A., Siddiqui I., Sharma P. Mycobacterium tuberculosis 6-kDa early secreted antigenic target (ESAT-6) protein downregulates lipopolysaccharide induced c-myc expression by modulating the extracellular signal regulated kinases 1/2. BMC Immunol. 2007, 8:24.
22. Trajkovic V., Singh G., Singh B., Singh S., Sharma P. Effect of Mycobacterium tuberculosis-specific 10-kilodalton antigen on macrophage release of tumor necrosis factor alpha and nitric oxide. Infect. Immun. 2002, 70(12):6558-6566.
23. Kaufmann S.H. Immunity to intracellular bacteria. Annu. Rev. Immunol. 1993, 11:129-163.
24. Graham M.B., Braciale V.L., Braciale T.J. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med. 1994, 180(4):1273-1282.
25. Lukacher A.E., Morrison L.A., Braciale V.L., Malissen B., Braciale T.J. Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones. J. Exp. Med. 1985, 162(1):171-187.
26. Mahon B.P., Katrak K., Nomoto A., Macadam A.J., Minor P.D., Mills K.H. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J. Exp. Med. 1995, 181(4):1285-1292.
27. J.L. Flynn, M.M. Goldstein, K.J. Triebold, B. Koller, B.R. Bloom, Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection, Proc. Natl. Acad. Sci. USA 89 (24) (1992) 12013-12017.
28. Ladel C.H., Daugelat S., Kaufmann S.H. Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice. contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 1995, 25(2):377-384.
29. Canaday D.H., Ziebold C., Noss E.H., Chervenak K.A., Harding C.V., Boom W.H. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J. Immunol. 1999, 162(1):372-379.
30. A. Lalvani, R. Brookes, R.J. Wilkinson, A.S. Malin, A.A. Pathan, P. Andersen, H. Dockrell, G. Pasvol, A.V. Hill, Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis, Proc. Natl. Acad. Sci. USA 95 (1) (1998) 270-275.
31. Ulrichs T., Munk M.E., Mollenkopf H., Behr-Perst S., Colangeli R., Gennaro M.L., Kaufmann S.H. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur. J. Immunol. 1998, 28(12):3949-3958.
32. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K.J., Podack E.R., Zinkernagel R.M., Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994, 369(6475):31-37.
33. Kojima H., Shinohara N., Hanaoka S., Someya-Shirota Y., Takagaki Y., Ohno H., Saito T., Katayama T., Yagita H., Okumura K., et al., Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1994, 1(5):357-364.
34. B. Lowin, F. Beermann, A. Schmidt, J. Tschopp, A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity, Proc. Natl. Acad. Sci. USA 91 (24) (1994) 11571-11575.
35. J.W. Heusel, R.L. Wesselschmidt, S. Shresta, J.H. Russell, T.J. Ley, Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells, Cell 76 (6) (1994) 977-987.
36. J. Pardo, A. Bosque, R. Brehm, R. Wallich, J. Naval, A. Mullbacher, A. Anel, M.M. Simon, Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis, J. Cell Biol. 167 (3) (2004) 457-468.
37. De Saint Basile G., Fischer A. The role of cytotoxicity in lymphocyte homeostasis. Curr. Opin. Immunol. 2001, 13:549-554.
38. van Dommelen S.L., Sumaria N., Schreiber R.D., Scalzo A.A., Smyth M.J., Degli-Esposti M.A. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity 2006, 25(5):835-848.
39. Voskoboinik I., Smyth M.J., Trapani J.A. Perforin-mediated target-cell death and immune homeostasis. Nat. Rev. Immunol. 2006, 6(12):940-952.
40. Bell J.K., Goetz D.H., Mahrus S., Harris J.L., Fletterick R.J., Craik C.S. The oligomeric structure of human granzyme A is a determinant of its extended substrate specificity. Nat. Struct. Biol. 2003, 10(7):527-534.
41. D. Kaiserman, C.H. Bird, J. Sun, A. Matthews, K. Ung, J.C. Whisstock, P.E. Thompson, J.A. Trapani, P.I. Bird, The major human and mouse granzymes are structurally and functionally divergent, J. Cell Biol. 175 (4) (2006) 619-630.
42. S.P. Cullen, C. Adrain, A.U. Luthi, P.J. Duriez, S.J. Martin, Human and murine granzyme B exhibit divergent substrate preferences, J. Cell Biol. 176 (4) (2007) 435-444.
43. Barry M., Bleackley R.C. Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2002, 2(6):401-409.
44. Cooper A.M., D'Souza C., Frank A.A., Orme I.M. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect. Immun. 1997, 65(4):1317-1320.
45. Toossi Z., Mayanja-Kizza H., Kanost A., Edmonds K., McHugh M., Hirsch C. Protective responses in tuberculosis: induction of genes for interferon-gamma and cytotoxicity by Mycobacterium tuberculosis and during human tuberculosis. Scand. J. Immunol. 2004, 60(3):299-306.
46. Stenger S. Cytolytic T cells in the immune response to Mycobacterium tuberculosis. Scand. J. Infect. Dis. 2001, 33(7):483-487.
47. Madhan Kumar M., Meenakshi N., Sundaramurthi Jagadish C., Kaur Gurvinder, Mehra Narinder K., Raja Alamelu Immune response to Mycobacterium tuberculosis specific antigen ESAT-6 among south Indians. Tuberculosis 2010, 90:60-69.
48. M. Madhan Kumar, Jagadish C. Sundaramurthi, Narinder K. Mehra, Gurvinder Kaur, Alamelu Raja, Cellular immune response to Mycobacterium tuberculosis-specific antigen culture filtrate protein-10 in south India, Med. Microbiol. Immunol. 199 (1) (2010) 11-25.
49. Endsley J.J., Hogg A., Shell L.J., McAulay M., Coffey T., Howard C. C. F. Capinos Scherer, W. R. Waters, B. Nonnecke, D. M. Estes, B. Villarreal-Ramos, Mycobacterium bovis BCG vaccination induces memory CD4+ T cells characterized by effector biomarker expression and anti-mycobacterial activity. Vaccine 2007, 25(50):8384-8394.
50. Smith S.M., Klein M.R., Malin A.S., Sillah J., Huygen K., Andersen P., McAdam K.P., Dockrell H.M. Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia. Infect. Immun. 2000, 68(12):7144-7148.
51. Pardo J., Balkow S., Anel A., Simon M.M. The differential contribution of granzyme A and granzyme B in cytotoxic T lymphocyte-mediated apoptosis is determined by the quality of target cells. Eur. J. Immunol. 2002, 32(7):1980-1985.
52. Regner M., Pavlinovic L., Koskinen A., Young N., Trapani J.A., Mullbacher A. Cutting edge: rapid and efficient in vivo cytotoxicity by cytotoxic T cells is independent of granzymes A and B. J. Immunol. 2009, 183(1):37-40.
53. Thoma-Uszynski S., Stenger S., Modlin R.L. CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis. J. Immunol. 2000, 165(10):5773-5779.
54. E. Sahiratmadja, B. Alisjahbana, S. Buccheri, D. Di Liberto, T. de Boer, I. Adnan, R. van Crevel, M.R. Klein, K.E. van Meijgaarden, R.H. Nelwan, E. van de Vosse, F. Dieli, T.H. Ottenhoff, Plasma granulysin levels and cellular interferon-gamma production correlate with curative host responses in tuberculosis, while plasma interferon-gamma levels correlate with tuberculosis disease activity in adults, Tuberculosis (Edinb) 87 (4) (2007) 312-321.
55. Clayberger C., Krensky A.M. Granulysin. Curr. Opin. Immunol. 2003, 15(5):560-565.
56. T. Decker, M.L. Lohmann-Matthes, A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity, J. Immunol. Methods 115 (1) (1988) 61-69.
57. D.A. Lewinsohn, A.S. Heinzel, J.M. Gardner, L. Zhu, M.R. Alderson, D.M. Lewinsohn, Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells, Am. J. Respir. Crit. Care Med. 168 (11) (2003) 1346-1352.
58. Mustafa A.S., Shaban F.A., Al-Attiyah R., Abal A.T., El-Shamy A.M., Andersen P., Oftung F. Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules. Scand. J. Immunol. 2003, 57(2):125-134.
59. Shams H., Klucar P., Weis S.E., Lalvani A., Moonan P.K., Safi H., Wizel B., Ewer K., Nepom G.T., Lewinsohn D.M., Andersen P., Barnes P.F. Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles. J. Immunol. 2004, 173(3):1966-1977.
60. Kamath A.B., Woodworth J., Xiong X., Taylor C., Weng Y., Behar S.M. Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection. J. Exp. Med. 2004, 200(11):1479-1489.
61. Wang Q.M., Sun S.H., Hu Z.L., Zhou F.J., Yin M., Xiao C.J., Zhang J.C. Epitope DNA vaccines against tuberculosis: spacers and ubiquitin modulates cellular immune responses elicited by epitope DNA vaccine. Scand. J. Immunol. 2004, 60(3):219-225.